NovaBay Pharmaceuticals - 15 Year Stock Price History | NBY

Historical daily share price chart and data for NovaBay Pharmaceuticals since 2011 adjusted for splits and dividends. The latest closing stock price for NovaBay Pharmaceuticals as of June 04, 2026 is 1.21.
  • The all-time high NovaBay Pharmaceuticals stock closing price was 196363.00 on September 20, 2013.
  • The NovaBay Pharmaceuticals 52-week high stock price is 19.95, which is 1548.8% above the current share price.
  • The NovaBay Pharmaceuticals 52-week low stock price is 0.43, which is 64.5% below the current share price.
  • The average NovaBay Pharmaceuticals stock price for the last 52 weeks is 2.01.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
NovaBay Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2026 9.0269 29.3500 95.8000 1.1500 1.2100 -95.71%
2025 4.4562 2.0822 31.0000 1.5534 28.2000 1322.02%
2024 8.2289 21.9788 21.9788 1.2559 1.9831 -91.43%
2023 116.1222 271.8430 294.9790 23.1356 23.1356 -89.74%
2022 855.6897 1619.4900 1619.4900 145.7540 225.5720 -85.34%
2021 2924.5638 2955.5700 5789.6800 1538.5200 1538.5200 -45.71%
2020 3255.4660 2550.7000 6518.4500 1174.1300 2834.1100 9.37%
2019 3995.8706 4008.2400 12551.1000 1133.6400 2591.1900 -16.88%
2018 9803.0878 16599.8000 16599.8000 3117.5200 3117.5200 -80.00%
2017 15680.8414 13117.9000 19231.5000 9514.5100 15587.6000 16.67%
2016 11897.9602 8178.4300 20243.6000 7206.7400 13360.8000 63.37%
2015 50524.6050 64779.7000 92108.6000 8097.4600 8178.4300 -87.17%
2014 95506.6409 130572.0000 141706.0000 60730.9000 63767.5000 -48.78%
2013 139335.7401 114377.0000 196363.0000 92108.6000 124498.0000 8.85%
2012 128919.6728 134620.0000 170047.0000 95145.1000 114377.0000 -15.67%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.068B $0.010B
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds, which it has named Aganocide compounds, which are based upon small molecules that are generated by white blood cells that defend the body against invading pathogens. NovaBay believes that Aganocide compounds could form a platform on which to create a variety of products to address differing needs in the treatment and prevention of bacterial and viral infections, including Methicillin-Resistant Staphylococcus aureus.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $76.559B 25.84
UCB SA (UCBJY) Belgium $53.468B 0.00
Takeda Pharmaceutical (TAK) Japan $49.234B 8.99
Sandoz Group AG (SDZNY) Switzerland $37.752B 0.00
Otsuka Holdings, - (OTSKY) Japan $35.394B 13.90
Zoetis (ZTS) United States $31.815B 11.73
BeOne Medicines - (ONC) Switzerland $29.822B 60.81
Daiichi Sankyo, - (DSNKY) Japan $29.359B 16.77
Astellas Pharma (ALPMY) Japan $24.376B 9.16
United Therapeutics (UTHR) United States $22.849B 19.87
Merck (MKKGY) Germany $19.748B 13.58
Neurocrine Biosciences (NBIX) United States $16.251B 27.21
IPSEN (IPSEY) France $15.217B 0.00
Shionogi (SGIOY) Japan $14.807B 10.88
Ionis Pharmaceuticals (IONS) United States $12.542B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.63
Madrigal Pharmaceuticals (MDGL) United States $11.825B 0.00
Summit Therapeutics (SMMT) United States $11.084B 0.00
Orion OYJ (ORINY) Finland $10.968B 17.83
Corcept Therapeutics (CORT) United States $8.557B 227.74
Eisai (ESAIY) $7.000B 0.00
Ono Pharmaceutical (OPHLF) Japan $6.344B 13.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.217B 0.00
Oruka Therapeutics (ORKA) United States $5.149B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.139B 19.65
Stevanato Group S.p.A (STVN) Italy $5.130B 27.32
Grifols, S.A (GRFS) Spain $4.955B 0.00
Indivior Pharmaceuticals (INDV) United States $4.672B 12.73
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.280B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.842B 11.89
Crinetics Pharmaceuticals (CRNX) United States $3.730B 0.00
Definium Therapeutics (DFTX) United States $3.656B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $3.603B 0.00
Dyne Therapeutics (DYN) United States $3.450B 0.00
Relay Therapeutics (RLAY) United States $3.311B 0.00
Enliven Therapeutics (ELVN) United States $2.799B 0.00
Hypermarcas (HYPMY) Brazil $2.753B 8.15
Soleno Therapeutics (SLNO) United States $2.717B 228.83
BioCryst Pharmaceuticals (BCRX) United States $2.323B 7.03
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.254B 19.48
Nektar Therapeutics (NKTR) United States $2.220B 0.00
Ocular Therapeutix (OCUL) United States $2.183B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
Guardian Pharmacy Services (GRDN) United States $2.085B 41.89
Amylyx Pharmaceuticals (AMLX) United States $1.810B 0.00
Harrow (HROW) United States $1.581B 212.05
Ardelyx (ARDX) United States $1.574B 0.00
Aktis Oncology (AKTS) United States $1.324B 0.00
Xeris Biopharma Holdings (XERS) United States $1.191B 115.00
Savara (SVRA) United States $1.166B 0.00
Collegium Pharmaceutical (COLL) United States $1.085B 4.86
Xencor (XNCR) United States $1.039B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
ARS Pharmaceuticals (SPRY) United States $0.991B 0.00
Cronos Group (CRON) Canada $0.989B 0.00
Evotec AG (EVO) Germany $0.932B 0.00
Avalo Therapeutics (AVTX) United States $0.898B 0.00
Theravance Biopharma (TBPH) United States $0.854B 17.25
Esperion Therapeutics (ESPR) United States $0.814B 0.00
Zevra Therapeutics (ZVRA) United States $0.748B 9.96
Bioventus (BVS) United States $0.734B 11.72
Relmada Therapeutics (RLMD) United States $0.723B 0.00
Aclaris Therapeutics (ACRS) United States $0.676B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.661B 5.65
Ironwood Pharmaceuticals (IRWD) United States $0.623B 6.26
Aquestive Therapeutics (AQST) United States $0.592B 0.00
Altimmune (ALT) United States $0.570B 0.00
ProKidney (PROK) United States $0.550B 0.00
4D Molecular Therapeutics (FDMT) United States $0.545B 0.00
Achieve Life Sciences (ACHV) Canada $0.524B 0.00
Indaptus Therapeutics (INDP) United States $0.427B 0.00
Century Therapeutics (IPSC) United States $0.415B 0.00
Lexeo Therapeutics (LXEO) United States $0.396B 0.00
Elite Pharmaceuticals (ELTP) United States $0.390B 36.25
Larimar Therapeutics (LRMR) United States $0.380B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 15.57
Silence Therapeutics (SLN) United Kingdom $0.356B 0.00
USANA Health Sciences (USNA) United States $0.349B 10.50
Prelude Therapeutics (PRLD) United States $0.344B 0.00
OmniAb (OABI) United States $0.336B 0.00
Organogenesis (ORGO) United States $0.313B 81.00
Siga Technologies (SIGA) United States $0.311B 16.04
Akebia Therapeutics (AKBA) United States $0.292B 0.00
Lyell Immunopharma (LYEL) United States $0.279B 0.00
Surrozen (SRZN) United States $0.275B 0.00
Cybin (HELP) Canada $0.250B 0.00
Inhibikase Therapeutics (IKT) United States $0.243B 0.00
Profound Medical (PROF) Canada $0.238B 0.00
Protara Therapeutics (TARA) United States $0.231B 0.00
Minerva Neurosciences (NERV) United States $0.217B 0.00
Unicycive Therapeutics (UNCY) United States $0.216B 0.00
Karyopharm Therapeutics (KPTI) United States $0.204B 0.00
Korro Bio (KRRO) United States $0.200B 0.00
AleAnna (ANNA) United States $0.195B 20.93
Tonix Pharmaceuticals Holding (TNXP) United States $0.194B 0.00
Galectin Therapeutics (GALT) United States $0.184B 0.00
MediWound (MDWD) Israel $0.179B 0.00
Journey Medical (DERM) United States $0.177B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.154B 0.00
Enlivex (ENLV) Israel $0.148B 0.00
Rafael Holdings (RFL) United States $0.143B 0.00
NRx Pharmaceuticals (NRXP) United States $0.141B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Fractyl Health (GUTS) United States $0.138B 0.00
Pyxis Oncology (PYXS) United States $0.135B 0.00
Veraxa Biotech AG (VRXA) United States $0.131B 0.00
VAXART, INC (VXRT) United States $0.130B 3.57
Avita Medical (RCEL) United States $0.124B 0.00
Aldeyra Therapeutics (ALDX) United States $0.124B 0.00
Cardiol Therapeutics (CRDL) Canada $0.122B 0.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
Vivani Medical (VANI) United States $0.097B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.097B 0.00
China SXT Pharmaceuticals (SXTC) China $0.091B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.090B 0.00
Telomir Pharmaceuticals (TELO) United States $0.088B 0.00
Champions Oncology (CSBR) United States $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.083B 0.00
Heron Therapeutics (HRTX) United States $0.081B 0.00
Gain Therapeutics (GANX) United States $0.079B 0.00
Dominari Holdings (DOMH) United States $0.072B 0.00
Acrivon Therapeutics (ACRV) United States $0.068B 0.00
ElectroCore (ECOR) United States $0.067B 0.00
PMV Pharmaceuticals (PMVP) United States $0.061B 0.00
Context Therapeutics (CNTX) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Alaunos Therapeutics (TCRT) United States $0.053B 0.00
Talphera (TLPH) United States $0.051B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Incannex Healthcare (IXHL) Australia $0.039B 0.00
Nutriband (NTRB) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Lite Strategy (LITS) United States $0.030B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.023B 0.00
VYNE Therapeutics (VYNE) United States $0.022B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Tempest Therapeutics (TPST) United States $0.019B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Natural Alternatives (NAII) United States $0.016B 0.00
Scienture Holdings (SCNX) United States $0.016B 0.00
Vyome Holdings (HIND) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.014B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Mannatech (MTEX) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.009B 0.00
Jupiter Neurosciences (JUNS) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.008B 0.00
Wellgistics Health (WGRX) United States $0.008B 0.00
CDT Equity (CDT) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Biomerica (BMRA) United States $0.006B 0.00
Vivos Therapeutics (VVOS) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00